Comprehensive and translational pathobiology of COVID-19 based on cellular and molecular techniques.

Ali Akbar Samadani, Sogand Vahidi, Kosar Babaei, Seyedeh Elham Norollahi, Kourosh Delpasand, Elaheh Asghari Gharakhyli

Abstract readReview

In one paragraph

Review in Practical laboratory medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ali Akbar SamadaniGuilan Road Trauma Research Center, Trauma Institute, Guilan University of Medical Sciences, Rasht, Iran.

Sogand VahidiMedical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.

Kosar BabaeiNoncommunicable Diseases Research Center, Neyshabur University of Medical Sciences, Neyshabur, Iran.

Seyedeh Elham NorollahiCancer Research Center and Department of Immunology, Semnan University of Medical Sciences, Semnan, Iran.

Kourosh DelpasandDepartment of Medical Ethics, Guilan University of Medical Sciences, Rasht, Iran.

Elaheh Asghari GharakhyliDepartment of Microbiology, Gorgan Branch, Islamic Azad University, Gorgan, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The biggest health issue in the world right now is the COVID-19 pandemic. This outbreak has caused a lot more people to be hospitalized for pneumonia and serious health problems, leading to many deaths. This report talks about many studies that showed the causes and how common COVID-19 is, as well as how to diagnose it in clinics and labs, and how to prevent and control it. These studies are very important and directly related to COVID-19 to help manage the current public emergency. Many parts of this dangerous disease, like how it spreads, how to diagnose it, how it infects people, and how to treat it, are still not well understood. It's important that to prevent, diagnose, and treat COVID-19 well, we need research at the molecular and clinical levels, along with public health measures and medical treatments. Clearly, new treatments like mesenchymal stem cell therapy have shown great promise in this area. Here, we will talk about and show the advanced lab methods used to understand how COVID-19 spreads, how it is diagnosed, and how it can be treated.

Indexed as

COVID-19 virusDiagnosisLaboratory techniquesPathogenesisTransmission

Identifiers

PMID40895261

DOI10.1016/j.plabm.2025.e00497

PMCPMC12391832

What Socratic holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.